LDS/Medical Tests/Immunoreactive Insulin

Immunoreactive Insulin

Inside the pancreatic beta cell, a polypeptide termed preproinsulin is metabolized into three substances, each of which can be measured. One of these substances is insulin. Levels of insulin, either endogenous or exogenous, are measured to evaluate for disorders such as hypoglycemia, tumor induced hypoglycemia, ischemic heart disease, syndrome of insulin resistance, etc. At the time of collection an additional specimen for glucose can be obtained to validate the diagnosis. An insulin-to-glucose ratio of >0.3 is presumptive evidence of insulinoma. C-peptide is another substance that is metabolized from preproinsulin and can be used with serum insulin to distinguish insulinoma from surreptitious insulin use, since C-peptide will be absent with exogenous insulin use. Autoimmune syndromes are a rare cause of hypoglycemia characterized by elevated levels of insulin in the presence of either anti-insulin antibodies (insulin autoimmune syndrome) or anti-insulin receptor antibodies (type B insulin resistance). Both conditions may be associated with inappropriately elevated insulin, and both conditions may be associated with postprandial hypoglycemia, fasting hypoglycemia, or both. This test is therefore used in the evaluation of insulin-related diseases such as hypoglycemia, tumor induced hypoglycemia, ischemic heart disease, syndrome of insulin resistance, etc. Both glucose and insulin levels are determined and compared and the ratio is calculated.

  • Evaluation of insulin related diseases such as hypoglycemia, tumor induced hypoglycemia, ischemic heart disease, syndrome of insulin resistance, etc.
  • As an aid in diagnosis of type I diabetes mellitus

Increased in:

  • Insulin-resistant states such as type II diabetes mellitus
  • Uremia
  • Severe liver disease
  • Insulinoma or pancreatic islet cell tumor

Decreased in:

  • Type I diabetes mellitus
  • Hypopituitarism
Group uU/mL pmol/L
Adult 0.7–9.0 5–63
Type II Diabetic 0.7–25.0 5–174

Electrochemiluminescence immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).

Serum (SST). 

Stability

  • Ambient: 24 hours
  • Refrigerated: 7-14 days
  • Frozen: 60 days
C-peptide, Fasting Glucose, Insulin Antibody, Microalbuminuria, Pancreatic Polypeptides, Insulin like Growth Factor Binding Protein, Urinalysis, Liver Function Tests.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function. Clin Endocrinol (Oxf). 2011 Dec 9. doi: 10.1111/j.1365-2265.2011.04312.x. PMID: 22150917]
  • J Clin Endocrinol Metab. 2000;85:3222. [PMID: 10999812]
  • Endocrinol Metab Clin North Am. 1999 Sep;28(3):603-18 [PMID: 10500933]
  • Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login